The emergence of bioorthogonal reactions has greatly broadened the scope of biomolecule labeling and detecting. Of all the bioorthogonal reactions that have been developed, the …
BR Buckley, SE Dann, H Heaney - Chemistry–A European …, 2010 - Wiley Online Library
Dinuclear alkynylcopper (I) ladderane complexes are prepared by a robust and simple protocol involving the reduction of Cu2 (OH) 3OAc or Cu (OAc) 2 by easily oxidised alcohols …
G Li, X Wang, S Zong, J Wang, PS Conti… - Molecular …, 2014 - ACS Publications
CD13 receptor as a tumor vasculature biomarker has attracted great attention in cancer research. Through phage display screening, NGR-containing peptides have been …
FE Lui, R Kluger - Biochemistry, 2009 - ACS Publications
The clinical evaluation of stabilized tetrameric hemoglobin as alternatives to red cells revealed that the materials caused significant increases in blood pressure and related …
Y Kim, R Kluger - Organic & Biomolecular Chemistry, 2022 - pubs.rsc.org
Chemical cross-linking of human adult hemoglobin (Hb) prevents dissociation of the tetrameric (αβ) 2 protein into its constituent non-functional αβ dimers when present outside …
Synthesis of novel host-guest functionalized polymers is presented along with structural characterization using small-angle X-ray scattering (SAXS) of the resulting nanoparticles …
JG Schellinger, LM Danan-Leon, JA Hoch… - Journal of the …, 2011 - ACS Publications
A fully synthetic trivalent mimotope of gp120 conjugated to pan allelic HLA DR binding epitope was prepared using solid-phase peptide synthesis and optimized copper-catalyzed …
Y Kim, LL Huang, N Wu, R Kluger - Bioorganic Chemistry, 2024 - Elsevier
While cross-linked hemoglobin tetramers are functional acellular oxygen carriers, their ability to scavenge endogenous nitric oxide (NO) by endothelial pore penetration results in …
A Wang, S Singh, B Yu, DB Bloch, WM Zapol… - …, 2019 - Wiley Online Library
BACKGROUND Hemoglobin‐based oxygen carriers (HBOCs) are potential alternatives to red blood cells in transfusions. Clinical trials using early versions of HBOCs noted adverse …